MichaelJamesFergusonMD
Pediatric Hematology & Oncology • Louisville, KYAssociate Professor of Pediatrics, Indiana University School of Medicine
Dr. Ferguson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
411 E Chestnut St
# 4B
Louisville, KY 40202Phone+1 502-588-3600Fax+1 502-588-9536
Summary
- Medical Director, Solid Tumor Program
Medical Director, Pediatric Cancer Precision Genomics Program
Education & Training
Indiana University School of MedicineFellowship, Clinical Pharmacology, 2012 - 2014- Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- Indiana University School of MedicineResidency, Pediatrics, 2007 - 2010
- Indiana University School of MedicineClass of 2007
Certifications & Licensure
IN State Medical License 2010 - 2025
KY State Medical License 2024 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors Start of enrollment: 2017 Dec 28
- Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN Start of enrollment: 2022 Jan 21
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsDiagnostic Conundrum of a Sertoli Cell Tumor in a 2-Year-Old Girl with Peripheral Precocious Puberty and a Café-au-Lait Macule: A Case Report.Lauren A Ray, Deborah F Billmire, Michael J Ferguson, Erica A Eugster
Hormone Research in Paediatrics. 2024-04-16 - Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion.Nur P Damayanti, M Reza Saadatzadeh, Erika Dobrota, Josue D Ordaz, Barbara J Bailey
Scientific Reports. 2023-06-06 - 1 citationsPediatric precision oncology: "better three hours too soon than a minute too late".Mark Marshall, Jennifer Ivanovich, Morgan Schmitt, Amy Helvie, Lisa Langsford
Frontiers in Oncology. 2023-01-01
Press Mentions
Norton Children's New Chief of Pediatric Cancer Confident in 100% Survival Rates in the FutureNovember 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
